Core Guide

Wegovy vs Ozempic: What's the Difference?

They're both semaglutide. They're made by the same company. So what's actually different? Let's clear up the confusion between these two popular medications.

Updated January 2026 | 10 min read

The Quick Answer

Wegovy and Ozempic are the same medication - semaglutide - made by the same company (Novo Nordisk). The main differences are:

  • Ozempic is approved for type 2 diabetes (max dose 2mg)
  • Wegovy is approved for weight management (max dose 2.4mg)

That's the essential difference. Same active ingredient, same mechanism, but different approved uses and maximum doses. Everything else - side effects, how it works, injection technique - is identical.

For a deeper understanding of how semaglutide works, see our article on what is semaglutide.

Same Medication, Different Labels

Think of it like this: imagine a company makes a vitamin supplement. They sell it in a blue bottle for "energy" and a green bottle for "immune support." Same vitamin, different marketing and labeling.

Novo Nordisk did something similar with semaglutide. When they first developed it, they tested it for diabetes. It worked well for blood sugar control, so they got it approved for that purpose under the name Ozempic.

But doctors noticed something interesting: their diabetic patients were losing significant weight. This led to clinical trials specifically for weight loss, at higher doses. Those trials were successful, and Wegovy was born - semaglutide approved specifically for chronic weight management.

The medications are manufactured identically. The active ingredient is the same. The injection pens work the same way. The main differences are regulatory and commercial:

Feature Ozempic Wegovy
Active ingredient Semaglutide Semaglutide
Manufacturer Novo Nordisk Novo Nordisk
Approved for Type 2 diabetes Chronic weight management
Maximum dose 2mg weekly 2.4mg weekly
Available doses 0.25, 0.5, 1, 2mg 0.25, 0.5, 1, 1.7, 2.4mg
Injection frequency Weekly Weekly

Dosing Differences

The dosing schedules for both medications start similarly but diverge at higher doses.

Ozempic dosing schedule:

  • Weeks 1-4: 0.25mg (starting dose)
  • Weeks 5-8: 0.5mg
  • Week 9+: 1mg (typical maintenance for diabetes)
  • Optional: 2mg (if additional effect needed)

Wegovy dosing schedule:

  • Weeks 1-4: 0.25mg (starting dose)
  • Weeks 5-8: 0.5mg
  • Weeks 9-12: 1mg
  • Weeks 13-16: 1.7mg
  • Week 17+: 2.4mg (maintenance dose for weight loss)

Notice that Wegovy goes higher (2.4mg vs 2mg) and has an intermediate dose step (1.7mg) that Ozempic doesn't have. The higher maximum dose was specifically tested and approved for weight management.

For detailed dosing information, see our semaglutide dosing guide.

What Each Is Approved For

Ozempic's approved uses:

  • Improving blood sugar control in adults with type 2 diabetes
  • Reducing cardiovascular risk in adults with type 2 diabetes and heart disease

Wegovy's approved uses:

  • Chronic weight management in adults with BMI ≥30 (obesity)
  • Chronic weight management in adults with BMI ≥27 (overweight) with at least one weight-related condition
  • Chronic weight management in adolescents aged 12+ with obesity

What about using Ozempic for weight loss?

Many doctors prescribe Ozempic "off-label" for weight loss in patients without diabetes. This is legal and common. When a medication is approved for one condition, doctors can prescribe it for other conditions based on their medical judgment.

The main limitation is that Ozempic's maximum dose (2mg) is lower than Wegovy's maintenance dose (2.4mg). Some people achieve excellent results at 2mg, while others might benefit from the higher Wegovy dose.

Weight Loss Results

Published clinical research studied semaglutide 2.4mg (Wegovy's dose) specifically for weight loss. Key results:

  • Clinically significant weight loss over 68 weeks
  • About one-third of participants lost more than 20% of their body weight
  • Nearly 90% lost at least 5% of their body weight

For Ozempic at its diabetes doses (up to 2mg), weight loss in diabetes trials was around 10-12% on average - still substantial, but less than the higher Wegovy dose.

This makes sense: more medication generally means more effect (up to a point). The 2.4mg dose was specifically chosen because it balanced efficacy with tolerability.

For a detailed timeline of what to expect, see our article on GLP-1 weight loss timeline.

Which Should You Choose?

The choice often comes down to practical factors:

Consider Ozempic if:

  • You have type 2 diabetes (it's specifically approved for this)
  • Wegovy isn't available in your area
  • Cost is a significant concern (Ozempic is sometimes more accessible)
  • You achieve good results at doses up to 2mg

Consider Wegovy if:

  • Your primary goal is weight loss without diabetes
  • You want the officially approved weight loss option
  • You might need the higher 2.4mg dose for maximum effect
  • It's readily available in your area

Important to know:

In practice, many people use Ozempic for weight loss and achieve excellent results. The difference between 2mg and 2.4mg may not be significant for everyone. Some people find their optimal dose is actually lower than the maximum.

The best approach is working with a healthcare provider who can help you find the right medication and dose based on your individual situation, goals, and response.

Availability in Nigeria

In Nigeria, both brand-name options can be challenging to find consistently:

Brand-name Ozempic: Occasionally available through importers and specialty pharmacies in major cities. Supply is inconsistent and prices are high.

Brand-name Wegovy: Even less available than Ozempic. Wegovy was launched later and supply is constrained even in countries where it's officially marketed.

The practical solution: Many Nigerians access compounded semaglutide instead. Compounded versions are prepared by licensed compounding pharmacies. They're typically more affordable and more consistently available.

With compounded semaglutide, you're not choosing between "Ozempic" or "Wegovy" - you're just getting semaglutide at whatever dose your doctor prescribes. You can titrate up to 2.4mg or higher if needed.

For step-by-step guidance on accessing these medications, see our article on how to get GLP-1 medications in Nigeria.

Common Questions

Can I switch between Ozempic and Wegovy?

Yes, since they're the same medication, you can switch between them. Work with your doctor to manage the transition, especially if moving between different doses.

Is one safer than the other?

They have identical safety profiles since they're the same medication. The side effects, precautions, and contraindications are the same for both.

Why does Wegovy go to a higher dose?

The 2.4mg dose was specifically tested and found to be the optimal dose for weight loss. It provides more weight loss than lower doses while remaining tolerable for most people.

If I'm using Ozempic at 2mg, am I missing out?

Not necessarily. Many people achieve excellent results at 2mg. The additional 0.4mg in Wegovy provides incremental benefit, but some people don't need it. Your response is individual.

Do they look the same?

The pens are similar but not identical. Ozempic pens are typically labeled with blue, while Wegovy uses different branding. The injection technique is the same for both.

What about compounded semaglutide - is it Ozempic or Wegovy?

Neither, technically. Compounded semaglutide is prepared by licensed compounding pharmacies. It's just semaglutide - you can use it at any dose your doctor prescribes.

Key Takeaways

  • Wegovy and Ozempic contain the identical active ingredient: semaglutide
  • Ozempic is approved for diabetes (max 2mg), Wegovy for weight loss (max 2.4mg)
  • Side effects, mechanism, and injection technique are identical
  • Ozempic is commonly prescribed off-label for weight loss
  • Compounded semaglutide is often the most accessible option in Nigeria

Ready to Start Your Weight Loss Journey?

Our medical team can help you access semaglutide at the right dose for your goals.

Get Started Today

Related Articles

References

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021.
  2. Davies M, et al. Semaglutide 2.4 mg Once Weekly in Adults with Overweight or Obesity and Type 2 Diabetes (STEP 2). Lancet. 2021.

Medically Reviewed by Dr. Babatunde Afolabi

MBBS, FRCP, PhD - Endocrinology

Content reviewed by qualified healthcare professionals for accuracy.